Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Co-Organizer of upcoming S.E.E Summit interviews with AVRT
View:
Post by LithLover on Apr 20, 2022 5:35pm

Co-Organizer of upcoming S.E.E Summit interviews with AVRT

Posted on Stage's LinkedIn.  S.E.E Summit tomorrow April 21, 2022
--------------------
Healthy Conversations was thrilled to have hosted Jamie Reno on this month's Podcast. Jamie is an acclaimed journalist, bestselling author, patient advocate and three-time survivor of stage IV cancer. He is also co-organizer of the inaugural S.E.E. Summit, a virtual conference to be held on April 21, 2022 by Teen Cancer America (TCA). The summit will feature presentations by the leading researchers and oncologists from biotechnology companies that are turning the game-changing promise of liquid biopsies into reality. Online attendance is free, and registration is available at https://lnkd.in/gr2DQTXc

Watch The Interview
https://ow.ly/LCmG50IN0tR


https://www.youtube.com/watch?v=Fs3EaVPmFSs
Comment by Nailbiter1 on Apr 20, 2022 5:52pm
This post has been removed in accordance with Community Policy
Comment by Nailbiter1 on Apr 20, 2022 6:11pm
This post has been removed in accordance with Community Policy
Comment by 4real4ever on Apr 20, 2022 6:44pm
Not even able to clean his room and put his frames right on the walls -29 views-
Comment by Nailbiter1 on Apr 20, 2022 8:38pm
This post has been removed in accordance with Community Policy
Comment by 4real4ever on Apr 20, 2022 11:10pm
All done by you+Lithloser+gojoke+Mydrnzzz+JonnyToy+CBG+Tylerfake... LMAO Ciao Doug
Comment by Liked2Think on Apr 21, 2022 10:40am
you were actually boasting about just over one view per hour? oh look its up to a whole 72 views now!  haha what an absolute joke actually even better go ahead and check out StageGoingToZero's youtube page. one video 4 months ago has 1,600 views.  Thats decent right.  Well look at the rest of those views I mean just check out all those views!  wow Oh and you can scroll ...more  
StageZero Life Sciences Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities